Genetic testing in Israel: An overview

Annual Review of Genomics and Human Genetics

Volumn 10, Issue , 2009, Pages 175-192

  Rosner, Guy ^a   Rosner, Serena ^a   Orr Urtreger, Avi ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Carrier screening; Founder mutation; Genetic laboratory testing services; Jewish and non Jewish populations; Prenatal diagnosis

Indexed keywords

ARAB; AUTOSOMAL RECESSIVE DISORDER; DIAGNOSTIC TEST; GAUCHER DISEASE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; GENETIC SERVICE; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; ISRAEL; JEW; MICROARRAY ANALYSIS; PREDICTION; PREGNANCY; PREGNANCY TERMINATION; PRENATAL CARE; REVIEW;

FEMALE; FETAL DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; ISRAEL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 70350236490     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.030308.111406     Document Type: Review

References (74)

1. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, et al. 1997. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am. J. Hum. Genet. 60:505-514 (Pubitemid 27097598)
2. Altarescu G, Brooks B, Margalioth E, Eldar Geva T, et al. 2007. Simultaneous preimplantation genetic diagnosis for Tay-Sachs and Gaucher disease. Reprod. Biomed. Online 15:83-88 (Pubitemid 47162100)
3. Altarescu G, Renbaum P, Brooks PB, Margalioth EJ, Ben Chetrit A, et al. 2008. Successful polar body-based preimplantation genetic diagnosis for achondroplasia. Reprod. Biomed. Online 16:276-282 (Pubitemid 351291977)
4. Bach G, Zeigler M, Zlotogora J. 2007. Prevention of lysosomal storage disorders in Israel. Mol. Genet. Metab. 90:353-357 (Pubitemid 46484424)
5. Bar-Shira A, Rosner G, Rosner S, Goldstein M, Orr-Urtreger A. 2006. Array-based comparative genome hybridization in clinical genetics. Pediatr. Res. 60:353-358 (Pubitemid 44267752)
6. Basel-Vanagaite L, Taub E, Drasinover V, Magal N, Brudner A, et al. 2008. Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel. Genet. Test. 12:53-56
7. Basel-Vanagaite L, Taub E, Halpern GJ, Drasinover V, Magal N, et al. 2007. Genetic screening for autosomal recessive nonsyndromic mental retardation in an isolated population in Israel. Eur. J. Hum. Genet. 15:250-253 (Pubitemid 46111866)
8. Beutler E. 2007. Carrier screening for Gaucher disease: more harm than good? JAMA 298:1329-1331 (Pubitemid 47443347)
9. Beutler E, Nguyen NJ, Henneberger MW, Smolec JM, McPherson RA, et al. 1993. Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am. J. Hum. Genet. 52:85-88 (Pubitemid 23059051)
10. Broide E, Zeigler M, Eckstein J, Bach G. 1993. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel. Am. J. Med. Genet. 47:213-215 (Pubitemid 23240690)
11. Carmi R, Elbedour K, Stone EM, Sheffield VC. 1995. Phenotypic differences among patients with Bardet- Biedl syndrome linked to three different chromosome loci. Am. J. Med. Genet. 59:199-203
12. Carmi R, Elbedour K, Wietzman D, Sheffield V, Shoham-Vardi I. 1998. Lowering the burden of hereditary diseases in a traditional, inbred community: ethical aspects of genetic research and its application. Sci. Context 11:391-395
13. Charrow J. 2004. Ashkenazi Jewish genetic disorders. Fam. Cancer 3:201-206
14. Dangoor N, Gazit E, Sade M, Zimin B, Frydman M. 1995. [Multidisciplinary approach to counseling in Huntington's disease]. Harefuah 128:751-54, 824
15. Ekstein J, Katzenstein H. 2001. The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease. Adv. Genet. 44:297-310 (Pubitemid 33804460)
16. Feldman GE. 2001. Do Ashkenazi Jews have a higher than expected cancer burden? Implications for cancer control prioritization efforts. Isr. Med. Assoc. J. 3:341-346
17. Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, et al. 2002. The founder mutation MSH2*1906G->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am. J. Hum. Genet. 71:1395-1412 (Pubitemid 36015893)
18. Gan-Or Z, Giladi N, Rozovski U, Shifrin C, Rosner S, et al. 2008. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 70:2277-2283
19. Gavert N, Yaron Y, Naiman T, Bercovich D, Rozen P, et al. 2002. Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum. Mutat. 19:664
20. Gazit E, Lubomirov L, Munakov O, Topper A, Frydman M, et al. 1998. Distribution of CAG repeats in normal and Huntington's disease patients in Israel. Clin. Genet. 54:250-251 (Pubitemid 28425379)
21. Gofin R, Adler B, Palti H. 2004. Screening tests in prenatal care: a national study in Israel. Isr.Med. Assoc. J. 6:535-539 (Pubitemid 39232614)
22. Goldberg Y, Porat RM, Kedar I, Shochat C, Sagi M, et al. 2008. Mutation spectrum in HNPCC in the Israeli population. Fam. Cancer 7:309-317
23. Guillem JG, Rapaport BS, Kirchhoff T, Kolachana P, Nafa K, et al. 2003. A636P is associated with early-onset colon cancer in Ashkenazi Jews. J. Am. Coll. Surg. 196:222-225 (Pubitemid 36232066)
24. Hedayat KM, Shooshtarizadeh P, Raza M. 2006. Therapeutic abortion in Islam: contemporary views of Muslim Shiite scholars and effect of recent Iranian legislation. J. Med. Ethics 32:652-657 (Pubitemid 44782038)
25. Horowitz M, Pasmanik-Chor M, Borochowitz Z, Falik-Zaccai T, Heldmann K, et al. 1998. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population. Hum. Mutat. 12:240-244 (Pubitemid 28418893)
26. Jaber L, Bailey-Wilson JE, Haj-Yehia M, Hernandez J, Shohat M. 1994. Consanguineous matings in an Israeli-Arab community. Arch. Pediatr. Adolesc. Med. 148:412-415
27. Jaber L, Dolfin T, Shohat T, Halpern GJ, Reish O, Fejgin M. 2000. Prenatal diagnosis for detecting congenital malformations: acceptance among Israeli Arab women. Isr. Med. Assoc. J. 2:346-350 (Pubitemid 30662221)
28. Jaber L, Halpern GJ, Shohat T. 2000. Trends in the frequencies of consanguineous marriages in the Israeli Arab community. Clin. Genet. 58:106-110 (Pubitemid 30673908)
29. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. 1993. Tay-Sachs disease-carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network. JAMA 270:2307-2315
30. Kadouri L, Hubert A, Rotenberg Y, Hamburger T, Sagi M, et al. 2007. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations. J. Med. Genet. 44:467-471 (Pubitemid 47056875)
31. Kannai R, Chertok IR. 2006. Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population. Isr. Med. Assoc. J. 8:347-350 (Pubitemid 43805053)
32. Kedar-Barnes I, Rozen P. 2004. The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility. Fam. Cancer 3:193-199 (Pubitemid 39491734)
33. Kerem E, Kalman YM, Yahav Y, Shoshani T, Abeliovich D, et al. 1995. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum. Genet. 96:193-197
34. Lavie O, Gruber SB, Lejbkowicz F, Dishon S, Rennert G. 2008. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation. Am. J. Obstet. Gynecol. 199:148e1-3
35. Lerer I, Wang T, Peretz T, Sagi M, Kaduri L, et al. 1998. The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. Am. J. Hum. Genet. 63:272-274
36. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, et al. 1997. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am. J. Hum. Genet. 60:1059-1067 (Pubitemid 27194090)
37. Lynch HT, de la Chapelle A. 2003. Hereditary colorectal cancer. N. Engl. J. Med. 348:919-932
38. Lynch HT, Rubinstein WS, Locker GY. 2004. Cancer in Jews: introduction and overview. Fam. Cancer 3:177-192
39. Malcov M, Ben-Yosef D, Schwartz T, Mey-Raz N, Azem F, et al. 2005. Preimplantation genetic diagnosis (PGD) for Duchenne muscular dystrophy (DMD) by triplex-nested PCR. Prenat. Diagn. 25:1200-1205 (Pubitemid 43164740)
40. Malcov M, Naiman T, Yosef DB, Carmon A, Mey-Raz N, et al. 2007. Preimplantation genetic diagnosis for fragile X syndrome using multiplex nested PCR. Reprod. Biomed. Online 14:515-521 (Pubitemid 46584389)
41. Malcov M, Schwartz T, Mei-Raz N, Yosef DB, Amit A, et al. 2004. Multiplex nested PCR for preimplantation genetic diagnosis of spinal muscular atrophy. Fetal. Diagn. Ther. 19:199-206 (Pubitemid 38209783)
42. Mishori Dery A, Carmi R, Shoham Vardi I. 2007. Different perceptions and attitudes regarding prenatal testing among service providers and consumers in Israel. Community Genet. 10:242-251 (Pubitemid 47482084)
43. Navon R, Proia RL. 1991. Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alphasubunit of beta-hexosaminidase. Am. J. Hum. Genet. 48:412-419 (Pubitemid 21891605)
44. Nevo Y, Ahituv S, Yaron Y, Kedmi M, Shomrat R, et al. 2001. Novel mutations in the emerin gene in Israeli families. Hum. Mutat. 17:522
45. Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, et al. 2007. TheLRRK2G2019S mutation in Ashkenazi Jews with Parkinson disease: Is there a gender effect? Neurology 69:1595-1602 (Pubitemid 350287143)
46. Ostrer H. 2001. A genetic profile of contemporary Jewish populations. Nat. Rev. Genet. 2:891-898 (Pubitemid 33674035)
47. Peleg L, Karpati M, Gazit E, Raas-Rothschild A, Goldman B. 1994. Mutations of the hexosaminidase A gene in Ashkenazi and non-Ashkenazi Jews. Biochem. Med. Metab. Biol. 52:22-26 (Pubitemid 24216522)
48. Quint A, Lerer I, Sagi M, Abeliovich D. 2005. Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening. Am. J. Med. Genet. A 136:246-248 (Pubitemid 40967089)
49. Quintana-Murci L, Gal I, Bakhan T, Quach H, Sayar SH, et al. 2005. The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews. Fam. Cancer 4:85-88 (Pubitemid 40897807)
50. Raz AE, Atar M, Rodnay M, Shoham-Vardi I, Carmi R. 2003. Between acculturation and ambivalence: knowledge of genetics and attitudes towards genetic testing in a consanguineous Bedouin community. Community Genet. 6:88-95 (Pubitemid 37323447)
51. Remennick L. 2006. The quest for the perfect baby: Why do Israeli women seek prenatal genetic testing? Sociol. Health. Illn. 28:21-53
52. Roa BB, Boyd AA, Volcik K, Richards CS. 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat. Genet. 14:185-187 (Pubitemid 26338801)
53. Rozen P, Naiman T, Strul H, Taussky P, Karminsky N, et al. 2002. Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect. Cancer 94:2561-2568 (Pubitemid 34478068)
54. Rozen P, Shomrat R, Strul H, Naiman T, Karminsky N, et al. 1999. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology 116:54-57 (Pubitemid 29013493)
55. Sheffield VC, Stone EM, Carmi R. 1998. Use of isolated inbred human populations for identification of disease genes. Trends. Genet. 14:391-396 (Pubitemid 28505582)
56. Sheiner E, Shoham-Vardi I, Weitzman D, Gohar J, Carmi R. 1998. Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic. Eur. J. Obstet. Gynecol. Reprod. Biol. 76:141-146 (Pubitemid 28031901)
57. Sher C, Romano-Zelekha O, Green MS, Shohat T. 2003. Factors affecting performance of prenatal genetic testing by Israeli Jewish women. Am. J. Med. Genet. A 120A:418-422 (Pubitemid 37063781)
58. Sher C, Romano-Zelekha O, Green MS, Shohat T. 2004. Utilization of prenatal genetic testing by Israeli Moslem women: a national survey. Clin. Genet. 65:278-283 (Pubitemid 38443549)
59. Shohat M, Frimer H, Shohat-Levy V, Esmailzadeh H, Appelman Z, et al. 2003. Prenatal diagnosis of Down syndrome: ten year experience in the Israeli population. Am. J. Med. Genet. A 122A:215-222 (Pubitemid 37152866)
60. Simchoni S, Friedman E, Kaufman B, Gershoni-Baruch R, Orr-Urtreger A, et al. 2006. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc. Natl. Acad. Sci. USA 103:3770-3774 (Pubitemid 43376630)
61. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, et al. 1995. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet. 11:198-200
62. Toledano-Alhadef H, Basel-Vanagaite L, Magal N, Davidov B, Ehrlich S, et al. 2001. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am. J. Hum. Genet. 69:351-360 (Pubitemid 32695207)
63. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. 2002. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat. Diagn. 22:778-782
64. Yaron Y, Ochshorn Y, Heifetz S, Lehavi O, Sapir Y, Orr-Urtreger A. 2002. First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagn. Ther. 17:352-356 (Pubitemid 36160157)
65. Yaron Y, Schwartz T, Mey-Raz N, Amit A, Lessing JB, Malcov M. 2005. Preimplantation genetic diagnosis of Canavan disease. Fetal Diagn. Ther. 20:465-468 (Pubitemid 41197078)
66. Zimran A, Zaizov R, Zlotogora J. 1997. [Large scale screening for Gaucher's disease in Israel - a position paper by the National Gaucher Committee of the Ministry of Health]. Harefuah 133:107-108
67. Zlotogora J. 1997. Autosomal recessive diseases among Palestinian Arabs. J. Med. Genet. 34:765-766 (Pubitemid 27406201)
68. Zlotogora J. 2002. Molecular basis of autosomal recessive diseases among the Palestinian Arabs. Am. J. Med. Genet. 109:176-182 (Pubitemid 34438660)
69. Zlotogora J. 2002. Parental decisions to abort or continue a pregnancy with an abnormal finding after an invasive prenatal test. Prenat. Diagn. 22:1102-1106 (Pubitemid 35448397)
70. Zlotogora J, Bach G, Munnich A. 2000. Molecular basis of Mendelian disorders among Jews. Mol. Genet. Metab. 69:169-180 (Pubitemid 30241682)
71. Zlotogora J, Barges S, Bisharat B, Shalev SA. 2006. Genetic disorders among Palestinian Arabs. 4: genetic clinics in the community. Am. J. Med. Genet. A 140:1644-1646 (Pubitemid 44148250)
72. Zlotogora J, Haklai Z, Leventhal A. 2007. Utilization of prenatal diagnosis and termination of pregnancies for the prevention of Down syndrome in Israel. Isr. Med. Assoc. J. 9:600-602 (Pubitemid 47323416)
73. Zlotogora J, Reshef N. 1998. Prenatal testing for genetic disorders among Arabs. Prenat. Diagn. 18:219-224 (Pubitemid 28121140)
74. Zuckerman S, Lahad A, Shmueli A, Zimran A, Peleg L, et al. 2007. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases. JAMA 298:1281-1290 (Pubitemid 47443342)